• Genetic testing and the interpretation of results are highly technical and complex. The clinical testing laboratory must be accredited by the CLIA (Clinical Laboratory Improvement Amendments) Program, the state, and/or other applicable accrediting agencies. The accreditation process ensures that laboratories adhere to strict standards and guidelines for clinical testing. Test result reports to consumers should indicate the specifics of the laboratory's accreditation. A knowledgeable professional should be involved in the process of ordering a genetic test with medical implications and laboratory results should be interpreted and delivered by a board-certified genetics professional.
• Disclaimer: These recommendations are designed primarily as an educational resource for medical geneticists and other health-care providers to help them provide quality medical genetics services. Adherence to these recommendations does not necessarily assure a successful medical outcome. These recommendations should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, geneticists and other clinicians should apply their own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent, however, to document in the patient's record the rationale for any significant deviation from the recommendations.
• The consumer should be apprised of the potential for receiving results that can neither confirm nor rule out the possibility of disease or unexpected results that are unrelated to the specific reason for testing, as well as the implications of genetic test results for family members.
• The scientific evidence base describing the validity and utility of a genetic test should be clearly stated. Direct-to-consumer genetic test providers should provide easy-to-understand information with primary references documenting the scientific data on which a specific test is based.
• Privacy concerns must be addressed. Prior to testing, the consumer should be informed as to who will have access to test results, what processes are in place to protect these results, what will happen to the DNA sample once testing is complete, and whether the test results may have any personal or family-related implications for life, long-term care, or disability insurance. Finally, whether data generated from testing will be sold to or shared with third parties should be clearly disclosed, as should ownership of the sample and generated data.
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